Skip to content

Clinical trials

Phase 2 Myelodysplastic Syndromes trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myelodysplastic Syndromes Phase: Phase 2 Country / region: France Clear all

52 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20033
20041
20051
20064
20073
20092
20103
20112
20121
20133
20141
20155
20164
20181
20194
20201
20213
20223
20232
20254

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23
Terminated10
Recruiting5
Active, not recruiting5
Unknown status5
Withdrawn2
Enrolling by invitation2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Groupe Francophone des Myelodysplasies16
Novartis Pharmaceuticals4
Celgene3
Associazione Qol-one2
European Organisation for Research and Treatment of Cancer - EORTC2
Institut Paoli-Calmettes2
Agios Pharmaceuticals, Inc.1
Assistance Publique - Hôpitaux de Paris1
Celgene Corporation1
Centre Hospitalier Universitaire de Nice1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myelodysplastic Syndromes52
Leukemia, Myeloid, Acute19
Leukemia, Myelomonocytic, Chronic8
Anemia6
Anemia, Refractory, with Excess of Blasts3
Bone Marrow Diseases2
Congenital Abnormalities2
Cytopenia2
Hematologic Neoplasms2
Hodgkin Disease2

Trials

Showing 1 to 25 of 52. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.